Norwegian Centre for Clinical Cancer Research with an overall ambition to extend the lives and improve quality of life of patients with hard-to-treat cancers.
Norway
Joined November 2022
- Tweets157
- Following122
- Followers185
- Likes455
MATRIX retweeted
Today we are writing in @Aftenposten about the new #protontherapy centers soon to open @Oslounivsykehus and @haukeland_no.
Read to find out why the cyclotron at the Radiumhospital is named «Ellen Gleditsch».
@DNVA1 #EirikMalinen #MarianneGuren @UniOslo
e-avis.aftenposten.no/shared…
MATRIX retweeted
The international lung cancer day, started with a focus from the TV-show "GodMorgenNorge".
Despite important improvements for subgroups of patients, lung cancer is still a disease with a poor prognosis, and more research is needed. @Lungekreft
MATRIX retweeted
Nytt håp for #Brystkreftpasienter med hjernemetastaser! Studieresultater viser at Enhertu gir sterk effekt hos HER2-positive pasienter. Med godkjenning fra Beslutningsforum kan behandlingen tas i bruk umiddelbart. #Onkologi #Kreftforskning #ESMO2024
bit.ly/3XrImI5
MATRIX retweeted
Norwegian Cancer Symposium, Sept 9-10, 2024, celebrating 70 years of #CancerResearch at Institute for Cancer Research, @Oslounivsykehus, starts with >430 participants, speakers & invited guests. Look forward to talks by 15 invited speakers, 8 short talk speakers, and 118 posters.
MATRIX retweeted
PCM4EU’s white paper on molecular assays and molecular tumor boards for trial inclusion has been published in Journal of Internal Medicine👏 - many congratulations:
matrix-fkb.no/en/pcm4eu-news…
MATRIX retweeted
Looking forward to the PRIME-ROSE project meeting and the Opening Symposium of the PCM4EU Spring Academy April 3. The Opening Symposium is accessible also digitally - check out the attachment for program and link to the streaming: matrix-fkb.no/en/pcm4eu-news…
PCM4EU in Porto - warming up to the Spring Academy starting tomorrow with a good project meeting hosted by @IPOPorto. Thank you to the organizers for an excellent start of this event👏👏
MATRIX retweeted
The PCM4EU Spring Academy takes place in Porto on 3-6 April! Day 1 is open to the general Public on-site or digitally whereas the following three days are for registered on-site participants. Learn more and down-load the program:
matrix-fkb.no/en/pcm4eu-news…
#eucancerplan
MATRIX retweeted
Check out this excellent podcast about PRIME-ROSE, DRUP like clinical trials and how we are using a Community Advisory Board to recommend which hrQoL should be included in the PRIME-ROSE expansion cohorts.@HellandAslaug @BettinaRyll @PRIMEROSE_EU, @PCM4EU, @ulassen @KjetilTasken
PODCAST:
PRIME-ROSE: The EU’s DRUP Trial Champion
--> bit.ly/3umUKPj
@BettinaRyll @PRIMEROSE_EU @KjetilTasken @DuaneSchulthess @BSBHbyVT
MATRIX retweeted
#MyPath was recently represented at the @EUonQol_ Stakeholder Forum. The event “Asking the Right Questions: Assessing Quality of Life in Cancer Patients,” aimed to enhance the #QoL for cancer patients and survivors in Europe.
#EUCancerMission
mypath-cancercare.eu/2023/12…
MATRIX retweeted
Our training and education team has produced almost 40 podcast episodes and replays from webinars in 1 year👏These are available both from the PCM4EU YouTube channel and our website. The latest addition is a series of episodes on cross-border access: matrix-fkb.no/en/pcm4eu-news…
MATRIX retweeted
#NobelPrize and how tightly coupled R&D and application must be - @JOlweus @jarottingen and I discuss in @Aftenposten the fantastic story of covid and cancer vaccine development as shown by Özlem Türeci @BioNTech in talks @DNVA1 and @Oslounivsykehus
aftenposten.no/meninger/kron…
MATRIX retweeted
🔬 Exciting Postdoc Opportunity
🔍 Join us in advancing Machine Learning for Cancer Immunotherapy.
We're looking for a talented Postdoctoral Researcher to join our team.
Explore the details and apply here:
2411.webcruiter.no/Main2/Rec…
MATRIX retweeted
TODAY: Olli Kallioniemi, director of @scilifelab, will present at the NCMM International seminar at 12:00:
«Data- and AI-driven life science: foundation models and hallmarks for cancer»
@UniOslo_MED @OsloSciencePark
med.uio.no/ncmm/english/news…
MATRIX retweeted
📑Check out our latest publication in @EurJImmunol where @garciadiaznuria @QianWei_ous and @KjetilTasken review the pipeline of small molecule inhibitors that have shown to affect regulatory T cells and may have applications in the treatment of cancer.
doi.org/10.1002/eji.20235044…
MATRIX retweeted
Så kjekt, så kjekt @HelseVest sin forskerpris for beste forskningsmiljø går til oss i #CCBIO. @forskningsradet @UiB @medofak_uib @haukeland_no
helse-bergen.no/nyheiter/det…
MATRIX retweeted
Dr. @asmundflobak's team at @NTNUnorway presents a systematic 📖 #review of studies that tested the performance of patient-derived #organoids to predict the effect of anti-cancer therapies in #ColorectalCancer, for chemotherapies, and more!
@SciReports | bitly.ws/YJ6e
MATRIX retweeted
We recruit one PHD candidate for cell lab work on functional precision medicine. Colon cancer cells direclty from patients are exposed to drugs to find the best therapy for each patient. Deadline Nov 22nd: jobbnorge.no/en/available-jo…
@NTNU @SINTEF @StOlavshospital @fkbmatrix
MATRIX retweeted
The ESMO 2023 Congress in Madrid is over. Read more about PRIME-ROSE activities during the conference here:
matrix-fkb.no/prime-rose-new…
